Chronic inflammation and coronary artery disease(CAD) have been research hotspots in recent years. In 2025, the American College of Cardiology (ACC) issued a Scientific Statement highlighting a broader panel of inflammatory markers for risk refinement, including clinically accessible indicators, including the est...
F. Xu, K. Yan, K.-X. Zhang et al.· European Heart Journal· 0 citations
Genetic risk affect prognosis of coronary heart disease. High platelet reactivity(HPR) under antiplatelet treatment is associated with increased risks of adverse cardiovascular events.
Our study aims to explore whether combining polygenic risk and HPR can provide incremental predictive value for acute myoc...
Y. Yao, N. Xu, X.-F. Lu et al.· European Heart Journal· 0 citations
In patients with coronary artery disease undergoing PCI and receiving clopidogrel, baseline peripheral blood eosinophil count showed a dual association with high on-treatment platelet reactivity and long-term cardiac death.
Z.-H. Ke, K. Yan, D. Yuan et al.· Zhonghua xin xue guan bing z...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.